Tou C - Search Results

1

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.

Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS. Goldman SC, et al. Among authors: tou c. Blood. 2001 May 15;97(10):2998-3003. doi: 10.1182/blood.v97.10.2998. Blood. 2001. PMID: 11342423 Free article. Clinical Trial.

2

Clinical trial of extended-release felodipine in pediatric essential hypertension.

Trachtman H, Frank R, Mahan JD, Portman R, Restaino I, Matoo TK, Tou C, Klibaner M. Trachtman H, et al. Among authors: tou c. Pediatr Nephrol. 2003 Jun;18(6):548-53. doi: 10.1007/s00467-003-1134-0. Epub 2003 Apr 17. Pediatr Nephrol. 2003. PMID: 12700955 Clinical Trial.

3

Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.

Izzo JL Jr, Weinberg MS, Hainer JW, Kerkering J, Tou CK; AMAZE. Izzo JL Jr, et al. J Clin Hypertens (Greenwich). 2004 Sep;6(9):485-93. doi: 10.1111/j.1524-6175.2004.03511.x. J Clin Hypertens (Greenwich). 2004. PMID: 15365275 Free PMC article. Clinical Trial.

4

Tiludronate therapy for Paget's disease of bone.

McClung MR, Tou CK, Goldstein NH, Picot C. McClung MR, et al. Among authors: tou ck. Bone. 1995 Nov;17(5 Suppl):493S-496S. doi: 10.1016/8756-3282(95)00282-1. Bone. 1995. PMID: 8573425 Clinical Trial.

5

Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.

Goldstein BJ, Rosenstock J, Anzalone D, Tou C, Ohman KP. Goldstein BJ, et al. Among authors: tou c. Curr Med Res Opin. 2006 Dec;22(12):2575-90. doi: 10.1185/030079906x154169. Curr Med Res Opin. 2006. PMID: 17166340 Clinical Trial.

6

Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes.

Ratner RE, Parikh S, Tou C; GALLANT 9 Study Group. Ratner RE, et al. Among authors: tou c. Diab Vasc Dis Res. 2007 Sep;4(3):214-21. doi: 10.3132/dvdr.2007.042. Diab Vasc Dis Res. 2007. PMID: 17907111 Free article. Clinical Trial.

7

Efficacy and safety of saxagliptin in drug-naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trial.

Pan CY, Yang W, Tou C, Gause-Nilsson I, Zhao J. Pan CY, et al. Among authors: tou c. Diabetes Metab Res Rev. 2012 Mar;28(3):268-75. doi: 10.1002/dmrr.1306. Diabetes Metab Res Rev. 2012. PMID: 22081481 Clinical Trial.

8

Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trial.

Yang W, Pan CY, Tou C, Zhao J, Gause-Nilsson I. Yang W, et al. Among authors: tou c. Diabetes Res Clin Pract. 2011 Nov;94(2):217-24. doi: 10.1016/j.diabres.2011.07.035. Epub 2011 Aug 26. Diabetes Res Clin Pract. 2011. PMID: 21871686 Clinical Trial.

9

Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study.

Carlson GF, Tou CK, Parikh S, Birmingham BK, Butler K. Carlson GF, et al. Diabetes Ther. 2011 Sep;2(3):123-32. doi: 10.1007/s13300-011-0003-2. Epub 2011 Jun 24. Diabetes Ther. 2011. PMID: 22127822 Free PMC article.

10

Pharmacokinetic study of saxagliptin in healthy Chinese subjects.

Li H, Yang L, Tou CK, Patel CG, Zhao J. Li H, et al. Clin Drug Investig. 2012 Jul 1;32(7):465-73. doi: 10.2165/11598760-000000000-00000. Clin Drug Investig. 2012. PMID: 22668067 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters